Active Sequences Collection (ASC) database: A new tool to assign functions to protein sequences

Nucleic Acids Research

Volumn 31, Issue 1, 2003, Pages 379-382

  Facchiano, Angelo M ^b   Facchiano, Antonio ^a   Facchiano, Francesco ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGINYLGLYCYLASPARTIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ACTIVE SEQUENCE COLLECTION DATABASE; AMINO ACID SEQUENCE; COMPUTER INTERFACE; ENZYME SUBSTRATE; HUMAN; INFORMATION PROCESSING; INTERNET; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE DATABASE; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DATABASES, PROTEIN; OLIGOPEPTIDES; PEPTIDES; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSGLUTAMINASES; USER-COMPUTER INTERFACE;

EID: 0037254694     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg042     Document Type: Review

References (30)

1. Jeffery,C.J. (1999) Moonlighting proteins. Trends Biochem. Sci., 24, 8-11.
2. Horton,M.A. (1999) Arg-Gly-Asp (RGD) peptides and peptidomimetics as therapeutics: relevance for renal diseases. Exp. Nephrol., 7, 178-184.
3. Ruoslahti,E., (1996) RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol., 12, 697-715.
4. Hostetter,M.K. (2000) RGD-mediated adhesion in fungal pathogens of humans, plants and insects. Curr. Opin. Microbiol., 3, 344-348.
5. Wang,W., Borchardt,R.T. and Wang,B. (2000) Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists. Curr. Med. Chem., 7, 437-453.
6. Urtreger,A., Porro,F., Puricelli,L., Werbajh,S., Baralle,F.E., Bal de Kier Joffe,E., Kornblihtt,A.R. and Muro,A.F. (1998) Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis. Int. J. Cancer, 78, 233-241.
7. Buerkle,M.A., Pahernik,S.A., Sutter,A., Jonczyk,A., Messmer,K. and Dellian,M. (2002) Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br. J. Cancer, 86, 788-795.
8. Riecke,B., Chavakis,E., Bretzel,R.G., Linn,T., Preissner,K.T., Brownlee,M. and Hammes,H.P. (2001) Topical application of integrin antagonists inhibits proliferative retinopathy. Horm. Metab. Res., 33, 307-311.
9. Peterson,J.A., Couto,J.R., Taylor,M.R. and Ceriani,R.L. (1995) Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Cancer Res., 55, 5847s-5851s.
10. Steed,D.L., Ricotta,J.J., Prendergast,J.J., Kaplan,R.J., Webster,M.W., McGill,J.B. and Schwartz,S.L. (1995) Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care, 18, 39-46.
11. Markland,F.S. (1998) Snake venoms and the hemostatic system. Toxicon, 36, 1749-1800.
12. Buckley,C.D., Pilling,D., Henriquez,N.V., Parsonage,G., Threlfall,K., Scheel-Toellner,D., Simmons,D.L., Akbar,A.N., Lord,J.M. and Salmon,M. (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature, 397, 534-539.
13. Chen,X., Wang,J., Fu,B. and Yu,L. (1997) RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys. Biochem. Biophys. Res. Commun., 234, 594-599.
14. Anuradha,C.D., Kanno,S. and Hirano,S. (2000) RGD peptide-induced apoptosis in human leukemia HL-60 cells requires caspase-3 activation. Cell Biol. Toxicol., 16, 275-283.
15. Adderley,S.R., and Fitzgerald,D.J. (2000) Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation. J. Biol. Chem., 275, 5760-5766.
16. Perlot,R.L.,Jr, Shapiro,I.M., Mansfield,K. and Adams,C.S. (2002) Matrix regulation of skeletal cell apoptosis II: role of Arg-Gly-Asp-containing peptides. J. Bone Miner. Res., 17, 66-76.
17. Gerlag,D.M., Borges,E., Tak,P.P., Ellerby,H.M., Bredesen,D.E., Pasqualini,R., Ruoslahti,E. and Firestein,G.S. (2001) Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res., 3, 357-361.
18. Kim,J., Smith,T., Idamakanti,N., Mulgrew,K., Kaloss,M., Kylefjord,H., Ryan,P.C., Kaleko,M. and Stevenson,S.C. (2002) Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization. J. Virol., 76, 1892-1903.
19. Szewczuk,Z., Wilczynski,A., Stefanowicz,P., Fedorowicz,W., Siemion,I.Z. and Wieczorek,Z. (1999) Immunosuppressory mini-regions of HLA-DP and HLA-DR. Mol. Immunol., 36, 525-533.
20. Vassilev,T.L., Kazatchkine,M.D., Van Huyerr,J.P., Mekrache,M., Bonnin,E., Mani,J.C., Lecroubier,C., Korinth,D., Baruch,D., Schriever,F. and Kaveri,S.V. (1999) Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg). Blood, 93, 3624-3631.
21. Chen,J.S. and Mehta,K. (1999) Tissue transglutaminase: an enzyme with a split personality. Int. J. Biochem. Cell Biol., 31, 817-836.
22. Greenberg,C.S., Birckbichler,P.J. and Rice,R.H. (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J., 5, 3071-3077.
23. Kim,S.Y., Jeitner,T.M. and Steinert,P.M. (2002) Transglutaminases in disease. Neurochem. Int., 40, 85-103.
24. Fesus,L. (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett., 328, 1-5.
25. Oliverio,S., Amendola,A., Di Sano,F., Farrace,M.G., Fesus,L., Nemes,Z., Piredda,L., Spinedi,A. and Piacentini,M. (1997) Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol. Cell. Biol., 17, 6040-6048.
26. De Laurenzi,V. and Melino,G. (2001) Gene disruption of tissue transglutaminase. Mol. Cell. Biol., 21, 148-155.
27. Nanda,N., Iismaa,S.E., Owens,W.A., Husain,A., Mackay,F. and Graham,R.M. (2001) Targeted inactivation of Gh/tissue transglutaminase II. J. Biol. Chem., 276, 20673-20678.
28. Facchiano,F., D'Arcangelo,D., Riccomi,A., Lentini,A., Beninati,S. and Capogrossi,M.C. (2001) Transglutaminase activity is involved in polyamine-induced programmed cell death. Exp. Cell Res., 271, 118-129.
29. Tucholski,J. and Johnson,G.V. (2002) Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J. Neurochem., 81, 710-791.
30. Boehm,J.E., Singh,U., Combs,C., Antonyak,M.A. and Cerione,R.A. (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J. Biol. Chem., 277, 20127-20130.